Amber Weller

Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol

Amber Weller, John Gleeson, Mario Alvarez-Jimenez, Patrick McGorry, Barnaby Nelson, Kelly Allott, Sarah Bendall, Cali Bartholomeusz, Peter Koval, Susy Harrigan, Brian O'Donoghue, Alex Fornito, Christos Pantelis, G Paul Amminger, Aswin Ratheesh, Andrea Polari, Stephen J Wood, Kristi van der El, Carli Ellinghaus, Jesse Gates, et al.

Journal article  |  2019  |  EARLY INTERVENTION IN PSYCHIATRY

Antipsychotic medication has been the mainstay of treatment for psychotic illnesses for over 60 years. This has been associated wi..

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial

Christopher G Davey, Andrew M Chanen, Sarah E Hetrick, Sue M Cotton, Aswin Ratheesh, Guenter P Amminger, John Koutsogiannis, Mark Phelan, Edward Mullen, Ben J Harrison, Simon Rice, Alexendra G Parker, Olivia M Dean, Amber Weller, Melissa Kerr, Amelia L Quinn, Lisa Catania, Nikolaos Kazantzis, Patrick D McGarry, Michael Berk

Journal article  |  2019  |  The Lancet Psychiatry

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin

Amelia L Quinn, Olivia M Dean, Christopher G Davey, Melissa Kerr, Susy M Harrigan, Sue M Cotton, Andrew M Chanen, Seetal Dodd, Aswin Ratheesh, G Paul Amminger, Mark Phelan, Amber Williams, Andrew Mackinnon, Francesco Giorlando, Shelley Baird, Simon Rice, Melissa O'Shea, Miriam R Schaefer, Edward Mullen, Sarah Hetrick, et al.

Journal article  |  2018  |  EARLY INTERVENTION IN PSYCHIATRY